America has approved one more anti-coronavirus vaccine. The Food and Drug Administration has given its nod to the vaccine developed by Johnson and Johnson. The federal agency said that the drug developed by Johnson and Johnson is a single-shot vaccine. The FDA said that it has granted only emergency use permission. The Johnson and Johnson vaccine is named Janssen Covid-19 Vaccine. It is the third anti-Covid drug to be approved by the FDA for emergency use. The two other vaccines are — Pfizer-BioNTech and Moderna. The latest authorization will allow the health authorities to distribute the J&J vaccine in the country for early inoculation. It will be used to vaccinate individuals who are over 18 years of age.
The FDA said that data provided by the company about the Janssen Covid-19 Vaccine showed that it is effective in preventing the spread of the virus. The vaccine is manufactured using adenovirus type 26. Ad26 is a specific type of virus that reacts inside the human body to deliver a distinctive spike protein of the virus. The agency noted that the nod will expand the availability of vaccines in the country. Making vaccines available to every citizen as early as possible is a challenge and the grant to J&J drug will ease the process. It is essential to make drug availability easier to break the chain of the virus. The virus has killed over five million people in the country.
The FDA cited company data to say that the J&J vaccine cannot replicate inside the body to cause illness. It helps the body to temporarily make the spike protein. It doesn’t cause illness or disease. It only triggers the immune system. The system then reacts defensively against the virus to protect against Covid-19. Moreover, it is administered as a single dose. The other vaccines are, however, administered as two-dose. The FDA said it is yet to determine how long the J&J vaccine can protect an individual against the virus. Also, there is no evidence available to show J&J vaccine helps prevent virus transmission from person to person.